SINOVAC BIOTECH LTD (AMEX:SVA)

Headlines for SINOVAC BIOTECH LTD

Benzinga's Top Pre- Market Gainers (PRGX, ENZN, NTAP, SHLD, GERN, SVA, SOLF)
Benzinga - Nov 19, 2009
PRG-Schultz International, Inc. (NASDAQ: PRGX) rose 8.42% to $5.28 in the pre-market session. The 52 week trading range for PRGX is $2.48 - $6.98. In the last six months, PRGX is up 67%. Enzon ...
Brean Murray Assumes Coverage on Sinovac Biotech (SVA) with a Buy
StreetInsider.com - Nov 18, 2009
Brean Murray assumes coverage on Sinovac Biotech (NYSE: SVA) with a Buy rating. Price target $11. Brean analyst says, "Not a one-hit wonder: industry leader with competitive advantages. 1 ...
Sinovac Files Shelf Registration Statement
PR Newswire - Nov 18, 2009
BEIJING , Nov. 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with ...
Sinovac Biotech files shelf registration statement with US Securities and Exchange Commission - News-Medical.net
Sinovac Biotech Ltd. Files Shelf Registration Statement
Reuters Key Development - Nov 18, 2009
来源:美通社
凤凰网 - Nov 17, 2009
BEIJING, Nov. 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it received a revised production license from ...